Effects of renal sympathetic denervation on 24-hour blood pressure variability

Frontiers in Physiology

Volumn 3 MAY, Issue , 2012, Pages

  Zuern, Christine S ^a   Rizas, Konstantinos D ^a   Eick, Christian ^a   Stoleriu, Cosmina ^a   Bunk, Lena ^a   Barthel, Petra ^b   Balletshofer, Bernd ^a   Gawaz, Meinrad ^a   Bauer, Axel ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arterial hypertension; Blood pressure variability; Renal sympathetic denervation

Indexed keywords

EID: 84865960269     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00134     Document Type: Article

References (30)

1. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L. Jr., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T. Jr., and Roccella, E. J. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560-2572.
2. Dabire, H., Lacolley, P., Chaouche-Teyara, K., Fournier, B., and Safar, M. E. (2002). Relationship between arterial distensibility and low-frequency power spectrum of blood pressure in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 39,98-106.
3. Esler, M. D., Krum, H., Sobotka, P. A., Schlaich, M. P., Schmieder, R. E., and Bohm, M. (2010). Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity HTN-2 trial): a randomised controlled trial. Lancet 376, 1903-1909.
4. Frattola, A., Parati, G., Castiglioni, P., Paleari, F., Ulian, L., Rovaris, G., Mauri, G., Di Rienzo, M., and Mancia, G. (2000). Lacidipine and blood pressure variability in diabetic hypertensive patients. Hypertension 36, 622-628.
5. Frattola, A., Parati, G., Cuspidi, C., Albini, F., and Mancia, G. (1993). Prognostic value of 24-hour blood pressure variability.J. Hypertens. 11, 1133-1137.
6. Hansen, T. W., Thijs, L., Li, Y., Boggia, J., Kikuya, M., Bjorklund-Bodegard, K., Richart, T., Ohkubo, T., Jeppe-sen, J., Torp-Pedersen, C., Dolan, E., Kuznetsova, T., Stolarz-Skrzypek, K., Tikhonoff, V., Malyutina, S., Casiglia, E., Nikitin, Y., Lind, L., San-doya, E., Kawecka-Jaszcz, K., Imai, Y., Wang, J., Ibsen, H., O'Brien, E., and Staessen, J. A. (2010). Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 55, 1049-1057.
7. Hsieh, Y. T., Tu, S. T., Cho, T. J., Chang, S. J., Chen, J. F., and Hsieh, M. C. (2012). Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5.5-year prospective analysis. Eur. J. Clin. Invest. 42, 245-253.
8. Kikuya, M., Hozawa, A., Ohokubo, T., Tsuji, I., Michimata, M., Matsubara, M., Ota, M., Nagai, K., Araki, T., Satoh, H., Ito, S., Hisamichi, S., and Imai, Y (2000). Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36, 901-906.
9. Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Siev-ert, H., Thambar, S., Abraham, W. T., and Esler, M. (2009). Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275-1281.
10. Mahfoud, F., Schlaich, M., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., Krum, H., Esler, M., and Bohm, M. (2011). Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123, 1940-1946.
11. Mancia, G., Bombelli, M., Facchetti, R., Madotto, F., Corrao, G., Tre-vano, F. Q., Grassi, G., and Sega, R. (2007a). Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e LoroAssociazioni Study. Hypertension 49, 1265-1270.
12. Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeld-sen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker-Boudier, H. A., Zanchetti, A., Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kris-tensen, S. D., Mcgregor, K., Sechtem, U., Silber, S., Tendera, M., Widim-sky, P., Zamorano, J. L., Erdine, S., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Lindholm, L. H., Manolis, A., Nilsson, P. M., Redon, J., Struijker-Boudier, H. A., Viigimaa, M., Adamopoulos, S., Bertomeu, V., Clement, D., Farsang, C., Gaita, D., Lip, G., Mallion, J. M., Manolis, A. J., O'Brien, E., Ponikowski, P., Ruschitzka, F., Tamargo, J., Van Zwi-eten, P., Waeber, B., Williams, B., The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension, and The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology. (2007b). 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. HeartJ. 28, 1462-1536.
13. Mancia, G., Di Rienzo, M., Parati, G., and Grassi, G. (1997). Sympathetic activity, blood pressure variability and end organ damage in hypertension. J. Hum. Hypertens. 11(Suppl. 1),S3-S8.
14. Mancia, G., Ferrari, A., Gregorini, L., Parati, G., Pomidossi, G., Bertinieri, G., Grassi, G., Di Rienzo, M., Pedotti, A., and Zanchetti, A. (1983). Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ. Res. 53, 96-104.
15. Mancia, G., Parati, G., Hennig, M., Flatau, B., Omboni, S., Glavina, F., Costa, B., Scherz, R., Bond, G., and Zanchetti, A. (2001). Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J. Hypertens. 19, 1981-1989.
16. Mena, L., Pintos, S., Queipo, N. V., Aizpurua, J. A., Maestre, G., and Sul-baran, T. (2005). A reliable index for the prognostic significance of blood pressure variability. J. Hypertens. 23, 505-511.
17. Muntner, P., Shimbo, D., Tonelli, M., Reynolds, K., Arnett, D. K., and Oparil, S. (2011). The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 57, 160-166.
18. Parati, G., Pomidossi, G., Albini, F., Malaspina, D., and Mancia, G. (1987). Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J. Hypertens. 5, 93-98.
19. Pringle, E., Phillips, C., Thijs, L., Davidson, C., Staessen, J. A., De Leeuw, P. W., Jaaskivi, M., Nachev, C., Parati, G., O'Brien, E. T., Tuomilehto, J., Webster, J., Bulpitt, C. J., and Fagard, R. H. (2003). Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J. Hypertens. 21,2251-2257.
20. Rothwell, P. M. (2010). Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 375, 938-948.
21. Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlof, B., Poulter, N. R., and Sever, P. S. (2010a). Effects of beta block-ers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. LancetNeurol. 9, 469-480.
22. Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlof, B., Sever, P. S., and Poulter, N. R. (2010b). Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375, 895-905.
23. Sander, D., Kukla, C., Klingelhofer, J., Winbeck, K., and Conrad, B. (2000). Relationship between circa-dian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 102, 1536-1541.
24. Schillaci, G., and Parati, G. (2010). Determinants of blood pressure variability in youth: at the roots of hypertension. J. Hypertens. 28, 660-664.
25. Schillaci, G., Pucci, G., and Parati, G. (2011). Blood pressure variability: an additional target for antihyper-tensive treatment? Hypertension 58, 133-135.
26. Schlaich,M.P.,Sobotka,P.A.,Krum,H., Lambert, E., and Esler, M. D. (2009). Renal sympathetic-nerve ablation for uncontrolled hypertension. N. Engl.J.Med. 361,932-934.
27. Stergiou, G. S., and Parati, G. (2011). How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability. Hypertension 57, 1041-1042.
28. Webb, A. J., Fischer, U., Mehta, Z., and Rothwell, P. M. (2010). Effects of antihypertensive-drug class on inter individual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375,906-915.
29. Webb, A. J., and Rothwell, P. M. (2011). Effect of dose and combination of antihypertensives on interindi-vidual blood pressure variability: a systematic review. Stroke 42, 2860-2865.
30. Zhang, Y., Agnoletti, D., Safar, M. E., and Blacher, J. (2011). Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension 58, 155-160.